Combination therapy for the targeted degradation of BCL6

WO2026117543A1PCT designated stage Publication Date: 2026-06-04ARVINAS OPERATIONS INC
View PDF 4 Cites 0 Cited by

Patent Information

Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
ARVINAS OPERATIONS INC
Filing Date
2025-11-25
Publication Date
2026-06-04

Smart Images

  • Figure IMGF000003_0001
    Figure IMGF000003_0001
  • Figure IMGF000003_0002
    Figure IMGF000003_0002
  • Figure IMGF000004_0001
    Figure IMGF000004_0001
Patent Text Reader

Abstract

The present disclosure relates to methods of treating cancer in a subject, comprising administering to the subject an effective amount of Compound A, or a pharmaceutically acceptable salt thereof and an effective amount of an additional anticancer agent.
Need to check novelty before this filing date? Find Prior Art